Entering text into the input field will update the search result below

AQS:CA Aequus Pharmaceuticals Inc.
Stock Price & Overview

$0.040.005 (+16.67%)2:15 PM 12/08/23
TSXV | $CAD | Market Close

Charts

FFO (FWD)
PE
Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

People Also Follow

Company Profile

Aequus Pharmaceuticals Inc. logo
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Employees
12
Founded
2013
Address
  • 200 Granville Street
  • Suite 2820
  • Vancouver, BC, V6C 1S4
  • Canada
Phone Number
604 336 7906
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.